Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Capital Expenditures (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Capital Expenditures for 6 consecutive years, with -$31.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 31.5% year-over-year to -$31.2 million, compared with a TTM value of $7.5 million through Sep 2025, down 71.16%, and an annual FY2024 reading of $2.2 million, up 10795.0% over the prior year.
  • Capital Expenditures was -$31.2 million for Q4 2025 at Viemed Healthcare, down from $27.3 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $27.3 million in Q3 2025 and bottomed at -$31.2 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $183687.5, with a median of $464500.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures skyrocketed 4581.0% in 2023, then tumbled 182892.31% in 2024.
  • Year by year, Capital Expenditures stood at $599000.0 in 2021, then crashed by 1911.02% to -$10.8 million in 2022, then surged by 100.12% to $13000.0 in 2023, then crashed by 182892.31% to -$23.8 million in 2024, then tumbled by 31.5% to -$31.2 million in 2025.
  • Business Quant data shows Capital Expenditures for VMD at -$31.2 million in Q4 2025, $27.3 million in Q3 2025, and $330000.0 in Q2 2025.